Professor and Chairman Rami Aqeillan  

Enterprise Bx is fortunate to have Professor Rami Aqeilan on its board. A highly trained Entrepreneur and distinguished leader. Professor Aqeilan is a highly accomplished researcher and leader in the fields of cancer biology and gene therapy. His career spans academic institutions, research institutes, and non-profit organizations, reflecting his dedication to both scientific discovery and its application to improve human health.

Scientific Director, CCRI - Cyprus Cancer Research Institute

Professor Aqeilan is a dedicated leader in the field of cancer research. He currently serves as the Scientific Director of the CCRI, where he spearheads the institute's efforts to advance critical research for effective cancer treatment.

Distinguished Academic Career ( Ohio State University & The University of Hebrew at Jerusalem)

Professor Aqeilan brings a wealth of experience to the board.  He holds a prestigious faculty position as a Professor at the Faculty of Medicine at the Hebrew University of Jerusalem, where he teaches and inspires future generations of scientists.  He also maintains an affiliation as an Adjunct Professor at The Ohio State University, potentially contributing through guest lectures or collaborative research projects.

Research Focus on Cancer and Beyond

Dr. Aqeilan's research delves into the complexities of cancer development, with a focus on understanding the genetic and molecular underpinnings of the disease.  His work investigates the role of both coding and non-coding genes in cancer pathways, knowledge that is essential for developing targeted therapies.  More recently, his research interests have expanded to explore the potential of gene therapy for childhood epilepsy.

Leadership and Innovation

Dr. Aqeilan is a recognized leader who is passionate about fostering a positive and supportive research environment.  His groundbreaking discovery in pancreatic cancer holds promise for a new treatment approach, highlighting his commitment to scientific innovation.